Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2021
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wolters Kluwer
Abstract
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Agarwal R, Rossignol P, Mayo MR, et al. Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Clin J Am Soc Nephrol. 2021;16(9):1407-1409. doi:10.2215/CJN.02890221
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Journal of the American Society of Nephrology
Source
PMC
Alternative Title
Type
Article